LifeVantage (LFVN) Competitors $14.48 +0.23 (+1.61%) Closing price 04:00 PM EasternExtended Trading$15.06 +0.58 (+4.04%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LFVN vs. DAWN, AVXL, PHVS, XERS, NTLA, EOLS, AVDL, CRON, PRAX, and OCSShould you be buying LifeVantage stock or one of its competitors? The main competitors of LifeVantage include Day One Biopharmaceuticals (DAWN), Anavex Life Sciences (AVXL), Pharvaris (PHVS), Xeris Biopharma (XERS), Intellia Therapeutics (NTLA), Evolus (EOLS), Avadel Pharmaceuticals (AVDL), Cronos Group (CRON), Praxis Precision Medicines (PRAX), and Oculis (OCS). These companies are all part of the "pharmaceutical products" industry. LifeVantage vs. Day One Biopharmaceuticals Anavex Life Sciences Pharvaris Xeris Biopharma Intellia Therapeutics Evolus Avadel Pharmaceuticals Cronos Group Praxis Precision Medicines Oculis LifeVantage (NASDAQ:LFVN) and Day One Biopharmaceuticals (NASDAQ:DAWN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership. Does the media favor LFVN or DAWN? In the previous week, Day One Biopharmaceuticals had 8 more articles in the media than LifeVantage. MarketBeat recorded 11 mentions for Day One Biopharmaceuticals and 3 mentions for LifeVantage. LifeVantage's average media sentiment score of 1.41 beat Day One Biopharmaceuticals' score of 0.68 indicating that LifeVantage is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeVantage 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Day One Biopharmaceuticals 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has more volatility and risk, LFVN or DAWN? LifeVantage has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, Day One Biopharmaceuticals has a beta of -1.24, meaning that its stock price is 224% less volatile than the S&P 500. Is LFVN or DAWN more profitable? LifeVantage has a net margin of 3.46% compared to Day One Biopharmaceuticals' net margin of 0.00%. LifeVantage's return on equity of 34.29% beat Day One Biopharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets LifeVantage3.46% 34.29% 15.04% Day One Biopharmaceuticals N/A -22.40%-19.79% Does the MarketBeat Community believe in LFVN or DAWN? LifeVantage received 169 more outperform votes than Day One Biopharmaceuticals when rated by MarketBeat users. Likewise, 77.97% of users gave LifeVantage an outperform vote while only 70.13% of users gave Day One Biopharmaceuticals an outperform vote. CompanyUnderperformOutperformLifeVantageOutperform Votes22377.97% Underperform Votes6322.03% Day One BiopharmaceuticalsOutperform Votes5470.13% Underperform Votes2329.87% Which has better earnings & valuation, LFVN or DAWN? LifeVantage has higher revenue and earnings than Day One Biopharmaceuticals. Day One Biopharmaceuticals is trading at a lower price-to-earnings ratio than LifeVantage, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeVantage$212.15M0.86$2.94M$0.5625.86Day One Biopharmaceuticals$131.16M5.56-$188.92M-$1.08-6.66 Do institutionals and insiders hold more shares of LFVN or DAWN? 35.3% of LifeVantage shares are held by institutional investors. Comparatively, 87.9% of Day One Biopharmaceuticals shares are held by institutional investors. 20.7% of LifeVantage shares are held by company insiders. Comparatively, 8.4% of Day One Biopharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer LFVN or DAWN? LifeVantage presently has a consensus price target of $30.50, indicating a potential upside of 110.64%. Day One Biopharmaceuticals has a consensus price target of $32.29, indicating a potential upside of 349.04%. Given Day One Biopharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Day One Biopharmaceuticals is more favorable than LifeVantage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeVantage 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Day One Biopharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryLifeVantage beats Day One Biopharmaceuticals on 12 of the 19 factors compared between the two stocks. Remove Ads Get LifeVantage News Delivered to You Automatically Sign up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFVN vs. The Competition Export to ExcelMetricLifeVantagePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$181.74M$6.32B$5.33B$7.57BDividend Yield1.05%3.23%5.11%4.33%P/E Ratio25.866.7921.7317.81Price / Sales0.86225.93379.1494.58Price / Cash19.0365.6738.1534.64Price / Book6.085.866.464.00Net Income$2.94M$141.86M$3.20B$247.23M7 Day Performance4.47%8.98%6.54%7.26%1 Month Performance-14.97%-12.65%-8.55%-6.26%1 Year Performance151.83%-11.99%10.33%-0.18% LifeVantage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFVNLifeVantage3.9826 of 5 stars$14.48+1.6%$30.50+110.6%+130.2%$181.74M$212.15M25.86260Positive NewsDAWNDay One Biopharmaceuticals2.4283 of 5 stars$7.02-2.8%$32.29+359.9%-47.6%$711.51M$131.16M-6.8260News CoverageAVXLAnavex Life Sciences3.3651 of 5 stars$8.33+1.7%$44.00+428.2%+105.4%$708.58MN/A-15.1540Gap DownPHVSPharvaris1.4073 of 5 stars$13.21-7.5%$40.50+206.6%-42.4%$690.75MN/A-4.7230XERSXeris Biopharma4.3081 of 5 stars$4.41flat$6.10+38.3%+117.8%$678.88M$203.07M-9.80290Short Interest ↑News CoveragePositive NewsHigh Trading VolumeNTLAIntellia Therapeutics4.3211 of 5 stars$6.54-1.4%$37.56+474.2%-69.1%$677.00M$57.88M-1.20600High Trading VolumeEOLSEvolus3.499 of 5 stars$10.24-4.2%$24.67+140.9%-15.1%$651.13M$266.27M-11.25170Analyst RevisionPositive NewsGap DownAVDLAvadel Pharmaceuticals2.2361 of 5 stars$6.69-1.6%$19.88+197.1%-51.7%$646.45M$169.12M-8.4770Analyst RevisionNews CoverageGap DownCRONCronos Group1.5723 of 5 stars$1.68-1.8%$3.00+78.6%-31.5%$642.65M$117.62M-12.92450PRAXPraxis Precision Medicines2.9244 of 5 stars$31.53-3.4%$123.33+291.2%-46.1%$635.74M$8.55M-3.06110Positive NewsOCSOculis1.9847 of 5 stars$14.37-7.3%$29.50+105.3%+43.5%$627.42M$980,000.00-7.452News CoverageHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Day One Biopharmaceuticals Competitors Anavex Life Sciences Competitors Pharvaris Competitors Xeris Biopharma Competitors Intellia Therapeutics Competitors Evolus Competitors Avadel Pharmaceuticals Competitors Cronos Group Competitors Praxis Precision Medicines Competitors Oculis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFVN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
